NCT05027321 Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies
| NCT ID | NCT05027321 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital St. Joseph, Marseille, France |
| Condition | Breast Neoplasm Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-10-11 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-10-11 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05027321 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Neoplasm Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05027321 currently recruiting?
Yes, NCT05027321 is actively recruiting participants. Contact the research team at vmilien@hopital-saint-joseph.fr for enrollment information.
Where is the NCT05027321 trial being conducted?
This trial is being conducted at Marseille, France.
Who is sponsoring the NCT05027321 clinical trial?
NCT05027321 is sponsored by Hospital St. Joseph, Marseille, France. The trial plans to enroll 100 participants.